Relative affinity and specificity of monoclonal antibodies against prostate-specific antigen

Tumor Biology

Volumn 20, Issue SUPPL. 1, 1999, Pages 24-27

  Jette, D C ^a   Kreutz, F T ^a   Suresh, M R ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Affinity; Epitope specificity; ISOBM TD 3 monoclonal antibodies; PSA

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; KALLIKREIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 1A5 6; MONOCLONAL ANTIBODY 2H11; MONOCLONAL ANTIBODY 4H5; MONOCLONAL ANTIBODY 5A10; MONOCLONAL ANTIBODY 94 6102; MONOCLONAL ANTIBODY 9B10; MONOCLONAL ANTIBODY E72; MONOCLONAL ANTIBODY E74; MONOCLONAL ANTIBODY E86; MONOCLONAL ANTIBODY E87; MONOCLONAL ANTIBODY E91; MONOCLONAL ANTIBODY F5; MONOCLONAL ANTIBODY H117; MONOCLONAL ANTIBODY H50; MONOCLONAL ANTIBODY M704; MONOCLONAL ANTIBODY MM1; MONOCLONAL ANTIBODY MP2; MONOCLONAL ANTIBODY PR1; MONOCLONAL ANTIBODY PR12; MONOCLONAL ANTIBODY PS101; MONOCLONAL ANTIBODY PS80; MONOCLONAL ANTIBODY PS98; MONOCLONAL ANTIBODY PSR217; MONOCLONAL ANTIBODY PSR222; MONOCLONAL ANTIBODY PSS233; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; ANTIGEN BINDING; CONFERENCE PAPER; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 0032746404     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000056526     Document Type: Conference Paper

References (10)

1. Lilja H, Abramson P-A, Lundwall A: Seminogelin, the predominant protein in human semen. J Biol Chem 1989;264:1894-1900.
2. Lilja H: A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein. J Clin Invest 1985;76:1899-1903.
3. Lundwall A, Lilja H: Molecular cloning of human prostate specific antigen cDNA. FEBS Lett 1987; 214:317-322.
4. Clements J: The human kallikrein gene family: A diversity of expression and function. Mol Cell Endocrinol 1994;99:C1-C6.
5. Stenman U-H, Leinonen J, Alfthan H: A complex between prostate-specific antigen and gamma antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostate cancer: Assay of the complex improves clinical sensitivity for cancer. Cancer Res 1991; 51:222-226.
6. Lilja H, Christensson A, Dahlén U, Matikainen M-T, Nilsson O, Pettersson K, Lövgren T: Prostate-specific antigen in serum occurs predominantly in complex with α1-antichymotrypsin. Clin Chem 1991; 37:1618-1625.
7. Christensson A, Björk T, Nilsson O, Dahlén U, Matikainen MT, Cockett ATK, Abrahamsson P-A, Lilja H: Serum prostate-specific antigen complexed to alpha-1-antichymotrypsin as an indicator of prostate cancer. J Urol 1993;150:100-105.
8. Bjartell A, Björk T, Matikainen M, Abrahamsson P-A, di Sant'Agnese A, Lilja H: Production of alpha-1-antichymotrypsin by PSA-containing cells of human prostate epithelium. Urology 1993;42:502-510.
9. Kreutz FT, Suresh MR: Novel bispecific immunoprobe for rapid and sensitive detection of prostate specific antigen. Clin Chem 1997;43: 649-656.
10. Jette DC, Kreutz T, Malcolm BA, Wishart DS, Noujaim AA, Suresh MR: Epitope mapping of prostate-specific antigen with monoclonal antibodies. Clin Chem 1996;42: 1961-1969.